首页> 外文期刊>European journal of pharmaceutical sciences >In vitro dissolution absorption system (IDAS2): Use for the prediction of food viscosity effects on drug dissolution and absorption from oral solid dosage forms
【24h】

In vitro dissolution absorption system (IDAS2): Use for the prediction of food viscosity effects on drug dissolution and absorption from oral solid dosage forms

机译:体外溶出系统(IDAs2):用于预测食物粘度对药物溶解和来自口服固体剂型的吸收的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Existing in vitro dissolution or permeation models to predict food effect are mainly based on Pharmacopeias' compendia) media, which specify such variables as pH, bile salts, lipolytic enzymes, and phospholipids content. However, the viscosity of food in the gastrointestinal (GI) tract is not taken into account, although it can affect both the dissolution of the oral solid dosage form and absorption of the released drug. Here, a new in vitro dissolution absorption system (IDAS2) is utilized, which comprises a dissolution apparatus USP2 (DISTEK) equipped with specially constructed permeability chambers containing Caco-2 monolayers, thereby allowing dissolution and transepithelial absorption to be ascertained simultaneously. The IDAS2 was used to evaluate the effect of medium viscosity on both the dissolution of oral solid dosage forms and absorption of released drugs. Such information, which is not ordinarily determined in dissolution and permeation studies, will be helpful to the formulators developing robust oral dosage forms. Commercially available solid dosage forms of ten model drugs from across all BCS classifications were used in this evaluation: metoprolol, minoxidil, and propranolol from BCS class 1; carbamazepine, ketoprofen, and simvastatin from BCS class 2; atenolol and ranitidine from BCS class 3; and acetazolamide and saquinavir from BCS class 4. The study revealed the applicability of IDAS2 as a tool for in vitro screening of dissolution and absorption of intact oral solid products to predict food viscosity effect. The most profound viscosity effect on dissolution and absorption was observed of solid dosage forms for the BCS class 2 compounds carbamazepine and simvastatin. A higher medium viscosity significantly slowed down the dissolution rate of tested BSC class 4 compounds acetazolamide and saquinavir, without significant effect on their absorption. The solid dosage forms least affected by the viscosity of the medium tested were the BCS class 1 compounds minoxidil and propranolol.
机译:存在于预测食物效果的体外溶解或渗透模型主要基于药典的“编辑”介质,其用pH,胆汁盐,脂肪酶和磷脂含量指定这种变量。然而,胃肠道(GI)道中的食物的粘度未被考虑,尽管它可以影响口腔固体剂型的溶解和释放的药物的吸收。这里,利用了一种新的体外溶出吸收系统(IDAs2),其包括配备有含有Caco-2单层的专门构造的渗透室的溶解装置USP2(DiStek),从而允许同时确定溶解和脱节性吸收。 IDAS2用于评估中粘度对口服固体剂型的溶解和释放药物的吸收的影响。这些信息通常在溶解和渗透研究中通常确定,将有助于制定强大的口腔剂型的配方素。在本评价中,使用来自所有BCS分类的可商购的固体剂型10种模型药物:来自BCS级别1的氟洛尔洛尔,明氧比和普萘洛尔; Carbamazepine,Ketoprofen和BCS类2的辛伐他汀;来自BCS第3级的阿替洛尔和雷硝酸盐;来自BCS等级的乙酰唑胺和Saquinavir。该研究揭示了IDAS2作为体外筛选溶解和吸收完整口腔固体产物的工具的工具,以预测食物粘度效应。对于BCS类2种化合物Carbamazepine和Simvastatin的固体剂型,观察到对溶解和吸收的最深刻粘度效应。更高的中粘度显着减缓了测试的BSC类化合物乙酰唑胺和苏基韦的溶解速率,对吸收没有显着影响。由所测试培养基的粘度影响的固体剂量是BCS类化合物的铌氧基硅和普萘洛尔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号